116 related articles for article (PubMed ID: 19864496)
1. Evaluation of a cardiovascular disease opportunistic risk assessment pilot ('Heart MOT' service) in community pharmacies.
Horgan JM; Blenkinsopp A; McManus RJ
J Public Health (Oxf); 2010 Mar; 32(1):110-6. PubMed ID: 19864496
[TBL] [Abstract][Full Text] [Related]
2. Engaging community pharmacists in the primary prevention of cardiovascular disease: protocol for the Pharmacist Assessment of Adherence, Risk and Treatment in Cardiovascular Disease (PAART CVD) pilot study.
Mc Namara KP; George J; O'Reilly SL; Jackson SL; Peterson GM; Howarth H; Bailey MJ; Duncan G; Trinder P; Morabito E; Finch J; Bunker S; Janus E; Emery J; Dunbar JA
BMC Health Serv Res; 2010 Sep; 10():264. PubMed ID: 20819236
[TBL] [Abstract][Full Text] [Related]
3. Opportunistic screening of cardiovascular disease risk factors in community pharmacies in Nigeria: a cross-sectional study.
Amadi C; Lawal F; Ajiboye W; Agbim R; Mbakwem A; Ajuluchukwu J; Oke DA
Int J Clin Pharm; 2020 Dec; 42(6):1469-1479. PubMed ID: 32960427
[TBL] [Abstract][Full Text] [Related]
4. Knowledge of cardiovascular disease risk factors and practice of primary prevention of cardiovascular disease by Community Pharmacists in Nigeria: a cross-sectional study.
Amadi CE; Lawal FO; Mbakwem AC; Ajuluchukwu JN; Oke DA
Int J Clin Pharm; 2018 Dec; 40(6):1587-1595. PubMed ID: 30474770
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular disease risk screening by pharmacists: a behavior change wheel guided qualitative analysis.
Almansour HA; Mekonnen AB; Aloudah NM; Alhawassi TM; Mc Namara K; Chaar B; Krass I; Saini B
Res Social Adm Pharm; 2020 Feb; 16(2):149-159. PubMed ID: 31027964
[TBL] [Abstract][Full Text] [Related]
6. A pilot study evaluating multiple risk factor interventions by community pharmacists to prevent cardiovascular disease: the PAART CVD pilot project.
McNamara KP; O'Reilly SL; Dunbar JA; Bailey MJ; George J; Peterson GM; Jackson SL; Janus ED; Bunker S; Duncan G; Howarth H
Ann Pharmacother; 2012 Feb; 46(2):183-91. PubMed ID: 22318928
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the Healthy LifeCheck programme: a vascular risk assessment service for community pharmacies in Leicester city, UK.
Hunt BD; Hiles SL; Chauhan A; Ighofose C; Bharakhada N; Jain A; Davies MJ; Khunti K
J Public Health (Oxf); 2013 Sep; 35(3):440-6. PubMed ID: 23479477
[TBL] [Abstract][Full Text] [Related]
8. Impact of socioeconomic deprivation on screening for cardiovascular disease risk in a primary prevention population: a cross-sectional study.
Lang SJ; Abel GA; Mant J; Mullis R
BMJ Open; 2016 Mar; 6(3):e009984. PubMed ID: 27000783
[TBL] [Abstract][Full Text] [Related]
9. Making a success of providing NHS Health Checks in community pharmacies across the Tees Valley: a qualitative study.
McNaughton RJ; Oswald NT; Shucksmith JS; Heywood PJ; Watson PS
BMC Health Serv Res; 2011 Sep; 11():222. PubMed ID: 21929809
[TBL] [Abstract][Full Text] [Related]
10. Involving the public and other stakeholders in development and evaluation of a community pharmacy alcohol screening and brief advice service.
Krska J; Mackridge AJ
Public Health; 2014 Apr; 128(4):309-16. PubMed ID: 24713598
[TBL] [Abstract][Full Text] [Related]
11. The influence of pharmacy and pharmacist characteristics on the secondary prevention of cardiovascular disease.
Puspitasari HP; Aslani P; Krass I
Int J Clin Pharm; 2015 Oct; 37(5):834-43. PubMed ID: 25964140
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of a novel pharmacy screening intervention to address the burden of type 2 diabetes and cardiovascular disease in an Arabic-speaking country.
Alzubaidi H; Hasan S; Saidawi W; Mc Namara K; Chandir S; Krass I
Diabet Med; 2021 Aug; 38(8):e14598. PubMed ID: 33969536
[TBL] [Abstract][Full Text] [Related]
13. An explanatory model of community pharmacists' support in the secondary prevention of cardiovascular disease.
Puspitasari HP; Costa DSJ; Aslani P; Krass I
Res Social Adm Pharm; 2016; 12(1):104-118. PubMed ID: 26001624
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular risk screening program in Australian community pharmacies.
Peterson GM; Fitzmaurice KD; Kruup H; Jackson SL; Rasiah RL
Pharm World Sci; 2010 Jun; 32(3):373-80. PubMed ID: 20217476
[TBL] [Abstract][Full Text] [Related]
15. The Inverse Care Law might not apply to preventative health services in community pharmacy.
Zonneveld S; Versace VL; Krass I; Clark RA; Shih S; Detert Oude Weme S; Mc Namara KP
Res Social Adm Pharm; 2021 May; 17(5):875-884. PubMed ID: 33092979
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of community pharmacists' preparedness for the provision of cardiovascular disease risk assessment and management services: A study with simulated patients.
Zolezzi M; Abdallah O; Kheir N; Abdelsalam AG
Res Social Adm Pharm; 2019 Mar; 15(3):252-259. PubMed ID: 29753643
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of community provision of a preventive cardiovascular programme - the National Health Service Health Check in reaching the under-served groups by primary care in England: cross sectional observational study.
Woringer M; Cecil E; Watt H; Chang K; Hamid F; Khunti K; Dubois E; Evason J; Majeed A; Soljak M
BMC Health Serv Res; 2017 Jun; 17(1):405. PubMed ID: 28615019
[TBL] [Abstract][Full Text] [Related]
18. Australian community pharmacists' awareness and practice in supporting secondary prevention of cardiovascular disease.
Puspitasari HP; Aslani P; Krass I
Int J Clin Pharm; 2013 Dec; 35(6):1218-28. PubMed ID: 24057435
[TBL] [Abstract][Full Text] [Related]
19. Widening access to cardiovascular healthcare: community screening among ethnic minorities in inner-city Britain - the Healthy Hearts Project.
Patel JV; Gunarathne A; Lane D; Lim HS; Tracey I; Panja NC; Lip GY; Hughes EA
BMC Health Serv Res; 2007 Nov; 7():192. PubMed ID: 18036225
[TBL] [Abstract][Full Text] [Related]
20. Diabetes and Cardiovascular Diseases Risk Assessment in Community Pharmacies: An Implementation Study.
Rondeaux S; Braeckman T; Beckwé M; Biset N; Maesschalck J; Duquet N; De Wulf I; Devroey D; De Vriese C
Int J Environ Res Public Health; 2022 Jul; 19(14):. PubMed ID: 35886551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
